As the American College of Cardiology meeting nears this coming weekend in Chicago, the curtain raisers have begun to appear. Last week, Forbes set the stage by discussing why the full study results, which will be presented for the first time, are important. And this morning, The Wall Street Journal does a look back on how the controversial Enhance trial became controversial.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments